WEBPORTAL
-
ARCHIMEDlife @ MSACL Salzburg: Mass Spectrometry Applications to Clinical Lab, 10.- 14.9.17
We are proud to be a regular part of MSACL – this year in Salzburg from 10.- 14. September 2017. Together with many other leading… Read more -
Our new Website is online!
ARCHIMEDlife News September 1, 2017WELCOME! We are happy to announce that our new website is online. From now on you can find all relevant information regarding laboratory diagnostics, rare… Read more -
Newborn Screening Awareness Month: Expanded Newborn Screening for dozens of metabolic diseases
ARCHIMEDlife News September 1, 2017September is Newborn Screening Awareness Month. Not only throughout this time we like to remind you, that you can easily test your baby for dozens… Read more -
Now published: A consensus guideline for newborn screening by mass spectrometry
An updated Consensus Guideline by worldwide experts is now available: See the publication of CLSI document NBS04-Ed2, Newborn Screening by Tandem Mass Spectrometry. The document… Read more -
Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving
Background: Primary infection of Toxoplasma gondii during pregnancy can be transmitted to the unborn child and may have serious consequences, including retinochoroiditis, hydrocephaly, cerebral calcifications,… Read more -
Genotype, phenotype and disease severity reflected by serum LysoGb3 levels in patients with Fabry disease
Publications July 5, 2017Background: Fabry disease (FD) is a rare X-linked lysosomal storage disease caused by mutations in the α-galactosidase A (GLA) gene causing deficiency of α-galactosidase A… Read more